Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy

by Viola Knop, Gerlinde Teuber, Hartwig Klinker, Bernd Möller, Jens Rasenack, Holger Hinrichsen, Tilman Gerlach, Ulrich Spengler, Peter Buggisch, Konrad Neumann, Christoph Sarrazin, Stefan Zeuzem, Thomas Berg
Published 2013-03-01

Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study.

by Peter Buggisch, Hans Heiken, Stefan Mauss, Bernd Weber, Maria-Christina Jung, Herbert Görne, Renate Heyne, Holger Hinrichsen, Dennis Hidde, Bettina König, Ana Gabriela Pires Dos Santos, Claus Niederau, Thomas Berg
Published 2021-01-01

Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study

by Edward J. Gane, Edwin DeJesus, Ewa Janczewska, Jacob George, Moises Diago, Mariliza Hendrique Da Silva, Henk Reesink, Igor Nikitin, Holger Hinrichsen, Stefan Bourgeois, Peter Ferenci, Umesh Shukla, Ronald Kalmeijer, Oliver Lenz, Bart Fevery, Chris Corbett, Maria Beumont, Wolfgang Jessner
Published 2017-06-01

Real-World Clinical Management of Patients with Primary Biliary Cholangitis—A Retrospective Multicenter Study from Germany

by Anne-Christin Beatrice Wilde, Charlotte Lieb, Elise Leicht, Lena Maria Greverath, Lara Marleen Steinhagen, Nina Wald de Chamorro, Jörg Petersen, Wolf Peter Hofmann, Holger Hinrichsen, Renate Heyne, Thomas Berg, Uwe Naumann, Jeannette Schwenzer, Johannes Vermehren, Andreas Geier, Frank Tacke, Tobias Müller
Published 2021-03-01

Treatment of naïve patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA.

by Benjamin Heidrich, Steffen B Wiegand, Peter Buggisch, Holger Hinrichsen, Ralph Link, Bernd Möller, Klaus H W Böker, Gerlinde Teuber, Hartwig Klinker, Elmar Zehnter, Uwe Naumann, Heiner W Busch, Benjamin Maasoumy, Undine Baum, Svenja Hardtke, Michael P Manns, Heiner Wedemeyer, Jörg Petersen, Markus Cornberg, HepNet Study Group
Published 2014-01-01